Mylan CEO in 2006 Decried Practice It’s Now Using on EpiPen

August 29, 2016 5:35 PM

24 0

Mylan CEO in 2006 Decried Practice It’s Now Using on EpiPen

In 2006, the drugmaker’s chief executive officer Heather Bresch said that “authorized generics” -- like the one her company is now introducing for EpiPen after an outcry over the drug’s price -- were a grave threat to the generic drug industry and hurt consumers.

Bresch, who was Mylan’s vice president of corporate development at the time, asked Congress in July 2006 to curb brand-name drugmakers’ practice of selling unbranded versions of their own medicines to thwart generic competition. She called the strategy “the single greatest threat to the generic indu...

Read more

To category page

Loading...